GFAP and Alzheimer disease: The GFAP+ profiles were trending down in the CA1 of the 16 months AD/cKO vs. AD (Fig. 3A ,B, p=0.35), while they were statistically higher in the cortex of the AD/cKO vs. AD (Fig. 3C, D, p=0.0002) and were trending up in the mPFC of the AD/cKO vs. AD (SFig.4D).